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THERAPEUTIC CHALLENGES IN NEONATES
Introduction
There is no other age as 
challenging as neonatal, 
due to the immaturity of 
organs and the
unpredictable 
pharmacokinetics, like the 
mode of application, 
biotransformation, 
distribution and 
elimination. The reasons 
for this challenge are 
specific receptor reactions, 
narrow therapeutic 
window, and burden of 
diseases specific only for 
this age, therefore lack of 
evidence for drug efficacy. 
The prescription of 
medicines in neonate is in 
direct relation of the 
gestational age, postnatal 
age, birth weight, 
associated morbidity. 
Many of the drugs are 
used as off-label, or even 
unlicensed, thus creating 
higher risk of medical 
errors, especially in NICU. 
These medicines can be 
used out of age, regimen, 
indication, or route of 
administration.
Objectives
The aim of this paper is 
to present the extent to 
which off-label and/or 
unlicensed medicines 
are used in neonatal unit 
within 
Obstetric&Gynecology 
Clinic in Skopje.
Results: there were 176 
prescriptions in total in
the investigated group;
148/176 (or 84,1%) of 
them were according to 
the prescribed drug 
guidelines, and 15,9% 
were off-label. In the 
control group, there 
were 110 prescriptions 
and only 3,6% were off-
label. The difference 
had highstatistical 
significance. 
This was an 
observational, cohort 
study, including 200 
healthy newborns, term 
or near-term, (control 
group) and 100 
newborns, receiving 
therapy, and non-
dependent of intensive 
care. Intravenous 
replacement solutions 
and blood products were 
not included.
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Results Cont’d
Discussion
Majority of the off-label 
reasons were use out of 
dose, indication, and age. 
The mostly prescribed off-
label medicines were 
Gentamicin, Cefotaxime, 
Amikacin, Furosemide, 
Dexamethasone.
It is worth mentioning that 
this is a part of a broader 
study, including newborns 
with more severe diseases, 
where much more 
prescriptions are given, and 
the risk of toxicity is manifold 
increased. These data show 
only the iceberg of the 
problem of neonatal 
pharmacotherapy. More 
detailed analysis will 
highlight this issue and give 
more information in terms of 
efficient neonatal treatment.
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